Gary Sender

Chief Financial Officer, SYNERGY PHARMACEUTICALS LLC.

Companies

Apnimed, Inc.Board member Jul 30, 2026 to now¹
iBio, Inc.Board member Oct 16, 2020 to now²
Harmony Biosciences Holdings, Inc.Board member Aug 18, 2020 to now³
SchrödingerBoard member Feb 5, 2020 to now⁴
Nabriva Therapeutics plcChief financial officer Dec 30, 2016 to Mar 2, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Schrödinger SDGR25,388 shares⁶$656.9K at $25.88Jun 22, 2026
iBio, Inc. IBIO9,191 shares⁷$7.2K at $0.78Jan 10, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 22, 2026Granted 8,141 shares of Schrödinger⁶
Jun 18, 2025Granted 5,997 shares of Schrödinger⁸
Jan 10, 2025Bought 9,191 shares at $2.72 of iBio, Inc.⁷
Jun 18, 2024Granted 5,000 shares of Schrödinger⁹
Jun 15, 2023Granted 6,250 shares of Schrödinger¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARApnimed, Inc., Board member
2
SEC EDGARiBio, Inc., Board member
3
SEC EDGARHarmony Biosciences Holdings, Inc., Board member
4
SEC EDGARSchrödinger, Board member
5
SEC EDGARNabriva Therapeutics plc, Chief financial officer
6
SEC EDGARSchrödinger shares after the filing of Jun 22, 2026
7
SEC EDGARiBio, Inc. shares after the filing of Jan 10, 2025
8
SEC EDGARForm 4 filed Jun 20, 2025
9
SEC EDGARForm 4 filed Jun 20, 2024
10
SEC EDGARForm 4 filed Jun 16, 2023